Fleet Bioprocessing has announced that it will be attending the European Gyrolab Seminar at the Grand Viscount Palace in Milan.
Taking place from 3-4 June, Fleet Bioprocessing will be presenting on the topic of Conjugate quality and its impact on Assay Performance.
The seminar is designed to allow existing Gyrolab users and those who wish to find out more about Gyros Protein Technologies and immunoassay advances to network.
Fleet Bioprocessing offer unrivalled expertise in the development, validation and manufacture of bioconjugates. The company also possesses industry-leading expertise in all aspects of immunoassay design, development and validation and are a certified assay transfer and development partner for the Gyrolab high-throughput immunoassay platform.
If you would like to discuss any aspect of bioconjugation, enzyme-linked immunosorbent assay (ELISA) development or Gyrolab assay development, please contact Fleet Bioprocessing using the contact form on this page.